Skip to content

The Effect of Honey Ointment on the Pain Severity and Healing of Women Genital Herpes Lesions.

The Effect of Honey Ointment on the Pain Severity and Healing of Women Genital Herpes Lesions.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160821029446N6
Enrollment
68
Registered
2020-03-24
Start date
2020-05-20
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

genital herpes.

Interventions

Intervention 1: Intervention group: This group will take oral aciclovir 400 mg 3 times daily for 7-10 days or until clinical symptoms resolve, with honey ointment 5 times daily until the skin returns

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Initial Herpes Genital Needs treatment for active Wounds Non-use of effective medications for Wound Healing (Anticoagulants, Anti-depressant, Alcohol, Glucocorticoids, immunosuppressive drugs, Chemotherapy, drugs, Psychotropic drugs) Lack of disease that disrupts Wound Healing (Chronic systemic diseases, Heart disease, kidney disease, Lung disease,  Coagulopathy, Immune deficiency,Connective tissue disorder,  Diabetes, Anemia, mental illnesses, hemophilia, Depression,  Malnutrition) Lack of Pregnancy or Lactation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of Pain. Timepoint: At the beginning of the study and 7 and 10 days after intervention. Method of measurement: VAS tool.;Healing of lesions. Timepoint: At the beginning of the study and 7 and 10 days after intervention. Method of measurement: Observation and Ruler.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahnoush Gerami

Tehran University of Medical Sciences

sh.gerami1990@gmail.com+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026